Participate in Studies of Groundbreaking Treatments

Excell Research Institute

Dedicated to Improving the Lives of Patients Through Clinical Research

Excell Research is a clinical research facility dedicated to improving the lives of patients through the advancement of safe and effective medication therapies.

Founded over 15 years ago, Excell Research partners with major pharmaceutical sponsors to conduct clinical research trials for new medications and treatments primarily in the areas of psychiatry; Alzheimer’s Disease and memory loss; women’s health; and other central nervous system conditions such as migraines and fibromyalgia.

Why Participate?

Clinical trials create a new opportunity for patients to receive alternative or more varied treatment, and to get up close and personal treatment from healthcare professionals. Often, clinical trials provide financially viable treatment options that may not have otherwise been available. By participating in a clinical trial, you would be aiding health care officials in their efforts to advance medical knowledge and to find new and better treatment options for patients.

 

New Treatments For Longer and Better-Quality Lives

The primary goal of all clinical trials is to determine that the new treatment is both effective and safe for patients. A clinical trial may seek a cure or new methods to ease the lives of patients with chronic illnesses. Participating in a clinical trial allows you to receive the most cutting-edge treatment or procedures in the medical field, and to assist in helping other patients live longer and better-quality lives.

 

Patient Safety

To ensure the safety of patients during clinical trials, Excell Research follows guidelines set by organizations such as the U.S. Food & Drug Administration and the Global International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Good Clinical Practices (ICH GCP).

Learn More About Our Clinical Trials

Answer a few simple questions to find out if you are a match for one of our current studies.